BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/12/2025 8:18:28 AM | Browse: 131 | Download: 639
 |
Received |
|
2025-04-02 08:40 |
|
Peer-Review Started |
|
2025-04-07 01:13 |
|
First Decision by Editorial Office Director |
|
2025-04-22 03:17 |
|
Return for Revision |
|
2025-04-22 03:17 |
|
Revised |
|
2025-05-01 16:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-06-24 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-06-24 08:07 |
|
Articles in Press |
|
2025-06-24 08:07 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-01 02:31 |
|
Publish the Manuscript Online |
|
2025-08-12 08:18 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Control Study |
| Article Title |
Clinical significance of differential plasma proteins levels in the diagnosis of epithelial ovarian cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Noha H Ibrahim, Mona S Abdellateif, Dina S Serag, Ahmed Laymouna, Mennatallah S Elaguizy and Radwa Marawan Abdel Halim |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mona S Abdellateif, MD, PhD, Department of Cancer Biology, National Cancer Institute, Cairo University, 1 Fom Elkhaligue, cairo 11796, Egypt. mona.sayed@nci.cu.edu.eg |
| Key Words |
Ovarian cancer; Human epididymis protein 4; Cancer antigen 125; Insulin-like growth factors-binding proteins 2; Thrombospondin 1 protein; Secreted phosphoprotein 1; Biomarkers |
| Core Tip |
Serum secreted phosphoprotein 1 (SPP1) can be a potential marker for the differentiation of patients with benign from those with malignant ovarian masses. insulin-like growth factors-binding proteins 2 (IGFBP2) and D-dimer could be potential markers for the diagnosis of patients with ovarian masses in relation to healthy controls. IGFBP2 could be a useful, sensitive diagnostic marker for epithelial ovarian cancer (EOC) patients. Also, combining SPP1 with cancer antigen 125 or thrombospondin 1 protein provides a high sensitivity (93.3%) and specificity (100%) for the detection of EOC patients. |
| Publish Date |
2025-08-12 08:18 |
| Citation |
Ibrahim NH, Abdellateif MS, Serag DS, Laymouna A, Elaguizy MS, Halim RMA. Clinical significance of differential plasma proteins levels in the diagnosis of epithelial ovarian cancer. World J Exp Med 2025; 15(3): 107711
|
| URL |
https://www.wjgnet.com/2220-315X/full/v15/i3/107711.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v15.i3.107711 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
